7 October 2021

PROs in cancer care

post

Recent studies have suggested that the integration of patient-reported outcomes (PROs) in clinical practice can improve symptom control and treatment response monitoring in the oncology setting. However, the adoption of PROs in cancer care is still in an early stage. This scoping study is the first to provide preliminary insights about the experiences and perspectives of oncology practitioners regarding PROs at a global level. It captured oncology practitioners’ clinical experience when using PROs and identified barriers in the delivery of cancer care. The results may be useful to develop implementation strategies that support routine inclusion of PRO reporting in cancer care settings. (Support Care Cancer. 2021 Sep 15;1-13. doi: 10.1007/s00520-021-06545-7. Online ahead of print.)

Anyone interested in future collaboration in this field of research is welcome to contact our key investigator Prof. Yin-ting CHEUNG from the School of Pharmacy, CUHK. Prof. Cheung had the privilege of pioneering the cognitive and psychosocial research program in Asian breast cancer patients. Her work involved characterising the pharmacological, biological and genetic determinants of brain function and other treatment-related complications in survivors of paediatric cancer.